KIMBERLY SLATE: Open Payments
NPI 1427031038 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,497 in 126 payments from 23 companies in 2025. Trend: 2023 $1,999 · 2024 $2,004 · 2025 $2,497
Food & beverage: $2,497
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $415 |
| Novo Nordisk Inc | 18 | $395 |
| Lilly USA, LLC | 13 | $362 |
| ABBVIE INC. | 19 | $270 |
| PFIZER INC. | 12 | $205 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $128 |
| Phathom Pharmaceuticals, Inc. | 9 | $114 |
| Antares Pharma, Inc. | 4 | $81 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $71 |
| Abbott Laboratories | 3 | $64 |
Products named: AIRSUPRA, MOUNJARO, UBRELVY, Ozempic, NURTEC ODT, Wegovy, BREZTRI, Kerendia.
Industry payments across TN — which companies pay providers there.
